FDA Recalls Zantac and All Ranitidine Products
The FDA has requested the removal of all Ranitidine (Zantac) products from the market. Studies have indicated that the widely popular heartburn medication may contain unacceptable levels of a dangerous carcinogen, N-Nitrosodimethylamine (NDMA.) Tests conducted by the analytical pharmacy Valisure found “extremely high levels of N-Nitrososdimethylamine in every lot” of ranitidine tested, including those produced by […]